Clinical effect of intracoronary administration of Tirofiban at different time points on STEMI patients undergoing PCI
Shicheng YU,Jun FENG,Zhaojin SUN,Haitao HUANG
DOI: https://doi.org/10.3969/j.issn.1009-5551.2018.05.005
2018-01-01
Abstract:Objective To investigate the clinical effect of intracoronary administration of Tirofiban at differ-ent time points in patients with acute ST-segment elevation myocardial infarction (STEMI)undergoing PCI.Methods A total of 198 STEMI patients were admitted to the hospital from January 2015 to Decem-ber 2017 were randomly divided into treatment group (n=101)and control group (n=97)).Two groups were treated with PCI therapy.In the treatment group,a load dose of Tirofiban Hydrochloride Inj ection was inj ected into the coronary artery through the guide tube and balloon dilation in the PCI operation.The control group was administered in the coronary artery before the balloon dilation of the PCI operation.The cases of regaining TIMI-3 blood flow (Thrombolysis In Acute Myocardial Infarction),postoperative 3 h ST-segment Resolution, left ventricular ej ection fraction (LVEF/％) and E/A value in 7 days, and incidence of major adverse cardiovascular events (MACE)during hospitalization were observed.Results (1)There were 95 cases in the treatment group regaining TIMI-3 blood flow immediately after PCI,while 82 cases in the control group.The difference was statistically significant (χ2=4.73,P =0.0296);(2)After 3 hours of PCI surgery,there were 79 cases in the treatment group with ST-segment complete recovery,14 cases with partial recovery,and 8 cases without falling down back at all,and the rate of ST-segment resolution was 92.1％.In the control group,there were 64 cases with ST-segment complete recovery,15 cases with partial recovery,and 18 cases without falling down back at all,and the rate of ST-segment resolution was 81.4％,where there was significant difference between the two groups (χ2=4.91,P =0.026);(3)After 7 d of PCI,there was no significant difference in LVEF between the two groups (t=1.45,P =0.148), while there was statistical significance in the E/A value between the two groups (t=2.62,P =0.0094);(4)7 cases of MACE in the treatment group occurred during hospitalization after PCI,while 16 cases in the control group,and the incidence were 6.93％ and 16.4％ respectively.The difference was statistically significant (χ2=5.21,P =0.022).Conclusion Intracoronary administration of Tirofiban at different time can affect the clinical efficacy of PCI in STEMI patients.Dilating the blockage or stenosis after intracoro-nary administration of Tirofiban with PCI can reverse the no-reflow situation and improve the ST segment resolution and left ventricular diastolic function,and reduce the incidence of maj or adverse cardiovascular events in short term.